Vancouver, British Columbia–(Newsfile Corp. – December 3, 2025) – Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (OTCQB: EQTRF) (“Altamira” or the “Company“), is pleased to announce the appointment of Dr. Richard Sillitoe as technical advisor to support exploration work across its Cajueiro Porphyry Gold District, Brazil. Dr. Sillitoe is recognized as one of the world’s leading […]

First Hydration Formula Powered by VINIA’s Blood Flow Technology Enters the $13 Billion U.S. Electrolyte Market Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – December 3, 2025) – BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology platform, announces the U.S. launch of VINIA Blood

Boulder, Colorado–(Newsfile Corp. – December 3, 2025) – Customer Paradigm, a digital agency focused on eCommerce and digital marketing, has announced the completion of over 22,584 projects since its founding in 2002. This milestone illustrates the company’s commitment to supporting clients and is a testament to its expertise in digital platforms. Customer Paradigm Logo To

LONDON, Dec. 03, 2025 (GLOBE NEWSWIRE) — Leading wealth advisory firm StratNova Capital today announced a major expansion of its global growth-equity sourcing framework, designed exclusively to enhance opportunities for Australian investors seeking early access to high-potential international companies. As market volatility reshapes traditional allocation strategies, StratNova Capital is reinforcing its position as a gateway

StratNova Capital Strengthens Australia's Access to Global Growth Equity With New Cross-Border Expansion Framework GlobeNewswire December 03, 2025 LONDON, Dec. 03, 2025 (GLOBE NEWSWIRE) — Leading wealth advisory firm StratNova Capital today announced a major expansion of its global growth-equity sourcing framework, designed exclusively to enhance opportunities for Australian investors seeking early access to high-potential

(CNSX:NIOB),(CNSX:NIOB.CN),(Boerse Frankfurt – Freiverkehr:IOR),(OTC US:NIOMF),(Other OTC:NIOMF), Completion of Fall 2025 Prospecting Program Across Seigneurie, Bardy, Blanchette and Sabot Properties Carbonatite Boulders and Pegmatite Zones Identified 262 Samples Submitted for Analysis Vancouver, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) — North American Niobium and Critical Minerals Corp. (CSE: NIOB) (FSE: IOR) (OTCQB: NIOMF) (“North American Niobium”

(NASDAQ:HTOO), Dublin, Ireland, Dec. 03, 2025 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel” or the “Company”), a leading provider of full-service energy engineering, advisory, and utility solutions, today announced that Al Shola Al Modea Gas Distribution LLC (“Al Shola Gas”), a full-service industrial gas solution provider in which the Company indirectly

(TSX-V:DGX),(NASDAQ:DGXX), This news release constitutes a “designated news release” for the purposes of the Company's amended and restated prospectus supplement dated November 18, 2025, to its short form base shelf prospectus dated May 15, 2025. MIAMI, Dec. 03, 2025 (GLOBE NEWSWIRE) — Digi Power X Inc. (“Digi Power X” or the “Company“) (Nasdaq: DGXX /

(NASDAQ:RLMD), Poster highlights 6-month follow-up data from the ongoing Phase 2 trial of NDV-01 in non-muscle invasive bladder cancer (NMIBC), with favorable overall safety Relmada plans to advance NDV-01, a sustained release intravesical formulation of gemcitabine/docetaxel (Gem/Doce), into Phase 3 studies in two indications in H1 2026 Company is focused on high-risk NMIBC and intermediate-risk

(NASDAQ:CGTX), PURCHASE, N.Y., Dec. 03, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that its expanded access program has reached full enrollment. Each of the individuals enrolled in the program are being treated with 100 mg of oral zervimesine daily